Literature DB >> 22802632

Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation.

Tao Liu1, Tanya M Laidlaw, Chunli Feng, Wei Xing, Shiliang Shen, Ginger L Milne, Joshua A Boyce.   

Abstract

Prostaglandin E(2) (PGE(2)) is an abundant lipid inflammatory mediator with potent but incompletely understood anti-inflammatory actions in the lung. Deficient PGE(2) generation in the lung predisposes to airway hyperresponsiveness and aspirin intolerance in asthmatic individuals. PGE(2)-deficient ptges(-/-) mice develop exaggerated pulmonary eosinophilia and pulmonary arteriolar smooth-muscle hyperplasia compared with PGE(2)-sufficient controls when challenged intranasally with a house dust mite extract. We now demonstrate that both pulmonary eosinophilia and vascular remodeling in the setting of PGE(2) deficiency depend on thromboxane A(2) and signaling through the T prostanoid (TP) receptor. Deletion of TP receptors from ptges(-/-) mice reduces inflammation, vascular remodeling, cytokine generation, and airway reactivity to wild-type levels, with contributions from TP receptors localized to both hematopoietic cells and tissue. TP receptor signaling ex vivo is controlled heterologously by E prostanoid (EP)(1) and EP(2) receptor-dependent signaling pathways coupling to protein kinases C and A, respectively. TP-dependent up-regulation of intracellular adhesion molecule-1 expression is essential for the effects of PGE(2) deficiency. Thus, PGE(2) controls the strength of TP receptor signaling as a major bronchoprotective mechanism, carrying implications for the pathobiology and therapy of asthma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802632      PMCID: PMC3411985          DOI: 10.1073/pnas.1207816109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Prostaglandin E2 protects lower airways against bronchoconstriction.

Authors:  John M Hartney; Kenneth G Coggins; Stephen L Tilley; Leigh A Jania; Alysia Kern Lovgren; Laurent P Audoly; Beverly H Koller
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-08-19       Impact factor: 5.464

2.  Effects of thromboxane A2 antagonist on airway hyperresponsiveness, exhaled nitric oxide, and induced sputum eosinophils in asthmatics.

Authors:  H Aizawa; H Inoue; H Nakano; K Matsumoto; M Yoshida; S Fukuyama; H Koto; N Hara
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1998-09       Impact factor: 4.006

3.  Interaction of PGH synthase isozymes-1 and -2 with nonsteroidal anti-inflammatory drugs.

Authors:  W L Smith; E A Meade; D L Dewitt
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

4.  Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics.

Authors:  C Picado; J C Fernandez-Morata; M Juan; J Roca-Ferrer; M Fuentes; A Xaubet; J Mullol
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

5.  Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma.

Authors:  M Hoshino; J Sim; K Shimizu; H Nakayama; A Koya
Journal:  J Allergy Clin Immunol       Date:  1999-06       Impact factor: 10.793

6.  Suppression of allergic inflammation by the prostaglandin E receptor subtype EP3.

Authors:  Tomonori Kunikata; Hana Yamane; Eri Segi; Toshiyuki Matsuoka; Yukihiko Sugimoto; Satoshi Tanaka; Hiroyuki Tanaka; Hiroichi Nagai; Atsushi Ichikawa; Shuh Narumiya
Journal:  Nat Immunol       Date:  2005-04-03       Impact factor: 25.606

Review 7.  A genetic approach for studying the role of thromboxane A2 in the kidney.

Authors:  D W Thomas; T M Coffman
Journal:  Kidney Int Suppl       Date:  1998-09       Impact factor: 10.545

8.  Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation.

Authors:  Simon C Pitchford; Stefania Momi; Silvia Giannini; Lucio Casali; Domenico Spina; Clive P Page; Paolo Gresele
Journal:  Blood       Date:  2004-11-04       Impact factor: 22.113

9.  The immunomodulatory actions of prostaglandin E2 on allergic airway responses in the rat.

Authors:  James G Martin; Masaru Suzuki; Karim Maghni; Rosa Pantano; David Ramos-Barbón; Daizo Ihaku; François Nantel; Danielle Denis; Qutayba Hamid; William S Powell
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

10.  Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation.

Authors:  G M Gauvreau; R M Watson; P M O'Byrne
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

View more
  27 in total

1.  Platelet-driven leukotriene C4-mediated airway inflammation in mice is aspirin-sensitive and depends on T prostanoid receptors.

Authors:  Tao Liu; Denise Garofalo; Chunli Feng; Juying Lai; Howard Katz; Tanya M Laidlaw; Joshua A Boyce
Journal:  J Immunol       Date:  2015-04-22       Impact factor: 5.422

2.  Regulation of Th9-type pulmonary immune responses: a new role for COX-2.

Authors:  Joshua A Boyce; R Stokes Peebles
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

3.  A time-varying group sparse additive model for genome-wide association studies of dynamic complex traits.

Authors:  Micol Marchetti-Bowick; Junming Yin; Judie A Howrylak; Eric P Xing
Journal:  Bioinformatics       Date:  2016-06-13       Impact factor: 6.937

4.  PGI2 Controls Pulmonary NK Cells That Prevent Airway Sensitization to House Dust Mite Allergen.

Authors:  Bryan Simons; Maria E Ferrini; Sophia Carvalho; David J P Bassett; Zeina Jaffar; Kevan Roberts
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

5.  P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation.

Authors:  Jun Nagai; Barbara Balestrieri; Laura B Fanning; Timothy Kyin; Haley Cirka; Junrui Lin; Marco Idzko; Andreas Zech; Edy Y Kim; Patrick J Brennan; Joshua A Boyce
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

6.  Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.

Authors:  Tao Liu; Nora A Barrett; Yoshihide Kanaoka; Eri Yoshimoto; Denise Garofalo; Haley Cirka; Chunli Feng; Joshua A Boyce
Journal:  J Immunol       Date:  2017-12-27       Impact factor: 5.422

7.  Effects of fish oil supplementation on eicosanoid production in patients at higher risk for colorectal cancer.

Authors:  Maya N White; Martha J Shrubsole; Qiuyin Cai; Timothy Su; Jennings Hardee; John-Anthony Coppola; Sunny S Cai; Stephanie M Martin; Sandra Motley; Larry L Swift; Ginger L Milne; Wei Zheng; Qi Dai; Harvey J Murff
Journal:  Eur J Cancer Prev       Date:  2019-05       Impact factor: 2.497

Review 8.  MicroRNA-638 inhibits human airway smooth muscle cell proliferation and migration through targeting cyclin D1 and NOR1.

Authors:  Hongyu Wang; Huijuan Yao; Bing Yi; Kyosuke Kazama; Yan Liu; Deepak Deshpande; Jian Zhang; Jianxin Sun
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

9.  Histamine, carbachol, and serotonin induce hyperresponsiveness to ATP in guinea pig tracheas: involvement of COX-2 pathway.

Authors:  Luis M Montaño; Verónica Carbajal; Mario H Vargas; Luz M García-Hernández; Verónica Díaz-Hernández; Marco Checa; Carlos Barajas-López
Journal:  Pflugers Arch       Date:  2013-03-10       Impact factor: 3.657

10.  Identification of Four Novel Loci in Asthma in European American and African American Populations.

Authors:  Berta Almoguera; Lyam Vazquez; Frank Mentch; John Connolly; Jennifer A Pacheco; Agnes S Sundaresan; Peggy L Peissig; James G Linneman; Catherine A McCarty; David Crosslin; David S Carrell; Todd Lingren; Bahram Namjou-Khales; John B Harley; Eric Larson; Gail P Jarvik; Murray Brilliant; Marc S Williams; Iftikhar J Kullo; Erik B Hysinger; Patrick M A Sleiman; Hakon Hakonarson
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.